NL8104929A - Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan. - Google Patents

Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan. Download PDF

Info

Publication number
NL8104929A
NL8104929A NL8104929A NL8104929A NL8104929A NL 8104929 A NL8104929 A NL 8104929A NL 8104929 A NL8104929 A NL 8104929A NL 8104929 A NL8104929 A NL 8104929A NL 8104929 A NL8104929 A NL 8104929A
Authority
NL
Netherlands
Prior art keywords
scopolamine
anticholinergic
gastric acid
acid secretion
continuously
Prior art date
Application number
NL8104929A
Other languages
English (en)
Dutch (nl)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NL8104929A publication Critical patent/NL8104929A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8104929A 1980-11-12 1981-10-30 Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan. NL8104929A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH839180 1980-11-12
CH839180 1980-11-12

Publications (1)

Publication Number Publication Date
NL8104929A true NL8104929A (nl) 1982-06-01

Family

ID=4339605

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8104929A NL8104929A (nl) 1980-11-12 1981-10-30 Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan.

Country Status (13)

Country Link
EP (1) EP0052074B1 (fr)
JP (1) JPS57114508A (fr)
BE (1) BE891069A (fr)
CY (1) CY1457A (fr)
DE (2) DE3175894D1 (fr)
GB (1) GB2087234B (fr)
HK (1) HK4889A (fr)
IT (1) IT1172052B (fr)
MY (1) MY8700681A (fr)
NL (1) NL8104929A (fr)
NZ (1) NZ198942A (fr)
PH (1) PH19066A (fr)
ZA (1) ZA817796B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
IL76635A0 (en) * 1984-10-11 1986-02-28 Key Pharma Physiological means of enhancing transdermal delivery of drugs
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method
AU3512595A (en) * 1994-09-13 1996-03-29 Magainin Pharmaceuticals, Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
JP2001267000A (ja) 2000-03-21 2001-09-28 Sumitomo Wiring Syst Ltd 防水コネクタ
JO3510B1 (ar) * 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
JP6073231B2 (ja) * 2011-08-31 2017-02-01 興和株式会社 安定な医薬組成物
JP2017014292A (ja) * 2016-10-24 2017-01-19 ロート製薬株式会社 医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally

Also Published As

Publication number Publication date
ZA817796B (en) 1982-10-27
NZ198942A (en) 1991-04-26
EP0052074B1 (fr) 1987-02-04
BE891069A (fr) 1982-05-10
JPS57114508A (en) 1982-07-16
GB2087234A (en) 1982-05-26
DE3144504A1 (de) 1982-06-24
EP0052074A2 (fr) 1982-05-19
MY8700681A (en) 1987-12-31
IT1172052B (it) 1987-06-18
IT8149667A0 (it) 1981-11-10
JPH0150683B2 (fr) 1989-10-31
GB2087234B (en) 1986-06-25
CY1457A (en) 1989-07-21
DE3175894D1 (en) 1987-03-12
EP0052074A3 (en) 1983-04-13
HK4889A (en) 1989-01-27
PH19066A (en) 1985-12-17

Similar Documents

Publication Publication Date Title
US6165497A (en) Subsaturated nicotine transdermal therapeutic system
US5635204A (en) Method for transdermal induction of anesthesia, analgesia or sedation
US5186939A (en) Laminated composite for transdermal administration of fentanyl
US5364630A (en) Subsaturated nicotine transdermal therapeutic system
KR100703101B1 (ko) 부프레노르핀을 함유하는 서방성 진통제
JP5856573B2 (ja) 経皮デリバリーシステム
EP0708627B1 (fr) Procede et dispositif therapeutique d'administration de substitut de la nicotine par voie transcutanee ou buccale
US4031894A (en) Bandage for transdermally administering scopolamine to prevent nausea
US4262003A (en) Method and therapeutic system for administering scopolamine transdermally
US6974588B1 (en) Transdermal patch for delivering volatile liquid drugs
KR100267442B1 (ko) 아세틸살리실산을 함유하는 혈전증 치료용 및 암 예방용 경피적 투여시스템
RU2355387C2 (ru) Трансдермальный гранисетрон
WO2008021113A2 (fr) Méthodes transdermiques et systèmes pour traiter la maladie d'alzheimer
NO306444B1 (no) Laminatkonstruksjon for transdermal administrering av fentanyl
EP2790685A1 (fr) Système d'administration transdermique comprenant de la buprénorphine
JPH0684304B2 (ja) チモロール用経皮的系
NL8104929A (nl) Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan.
US4436741A (en) Method for administering scopolamine transdermally
EP1652523A1 (fr) Preparation pour absorption transdermique
EP0290262A2 (fr) Thérapie de l'angine de poitrine par le nitrate
EP0427741B1 (fr) Dispositif de distribution transcutanee sous-saturee
EP1449527A2 (fr) Patch transdermique pour administrer un principe actif volatile
JPH08501090A (ja) 活性物質としてペンチレンテトラゾールを用いた経皮的治療システム
Spieker et al. Transdermal β-blocker therapy in essential hypertension
AU682813B2 (en) Subsaturated transdermal delivery device

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed